594 related articles for article (PubMed ID: 35937834)
21. Combining beta-adrenergic and peroxisome proliferator-activated receptor gamma stimulation improves lipoprotein composition in healthy moderately obese subjects.
Hughes TA; Stentz F; Gettys T; Smith SR
Metabolism; 2006 Jan; 55(1):26-34. PubMed ID: 16324916
[TBL] [Abstract][Full Text] [Related]
22. Apolipoproteins A-I, B, and C-III in young adult Cherokee with metabolic syndrome with or without type 2 diabetes.
Wang W; Khan S; Blackett P; Alaupovic P; Lee E
J Clin Lipidol; 2013; 7(1):38-42. PubMed ID: 23351581
[TBL] [Abstract][Full Text] [Related]
23. ApoE and apoC-III-defined HDL subtypes: a descriptive study of their lecithin cholesterol acyl transferase and cholesteryl ester transfer protein content and activity.
Amaya-Montoya M; Pinzón-Cortés JA; Silva-Bermúdez LS; Ruiz-Manco D; Pérez-Matos MC; Jiménez-Mora MA; Mendivil CO
Lipids Health Dis; 2020 May; 19(1):106. PubMed ID: 32450892
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Serum Apolipoproteins and Traditional Lipids in Eyes with Diabetic Retinopathy in Indian Population: A Case Series.
Prakash G; Agrawal R; Satsangi SK; Prakash S
Middle East Afr J Ophthalmol; 2016; 23(2):212-4. PubMed ID: 27162455
[TBL] [Abstract][Full Text] [Related]
25. Characterization of apoA- and apoB-containing lipoprotein particles in a variant of familial apoA-I deficiency with planar xanthoma: the metabolic significance of LP-A-II particles.
Bekaert ED; Alaupovic P; Knight-Gibson CS; Laux MJ; Pelachyk JM; Norum RA
J Lipid Res; 1991 Oct; 32(10):1587-99. PubMed ID: 1797940
[TBL] [Abstract][Full Text] [Related]
26. Association between high-density lipoprotein cholesterol to apolipoprotein A ratio and diabetic retinopathy: A cross-sectional study.
Zhang C; Lin W; Xu Q; Li H; Xu C; Ma X; Hao M; Kuang H
J Diabetes Complications; 2023 Jun; 37(6):108471. PubMed ID: 37127002
[TBL] [Abstract][Full Text] [Related]
27. Fate of apolipoproteins C-1, C-iii, and E during lipolysis of human very low density lipoproteins in vitro.
Tam SP; Dory L; Rubinstein D
J Lipid Res; 1981 May; 22(4):641-51. PubMed ID: 7276737
[TBL] [Abstract][Full Text] [Related]
28. Lipid and apolipoprotein profiles of uremic dyslipoproteinemia--relation to renal function and dialysis.
Attman PO; Alaupovic P
Nephron; 1991; 57(4):401-10. PubMed ID: 2046821
[TBL] [Abstract][Full Text] [Related]
29. Plasma levels of apolipoproteins C-III, A-IV, and E are independently associated with stable atherosclerotic cardiovascular disease.
Dittrich J; Beutner F; Teren A; Thiery J; Burkhardt R; Scholz M; Ceglarek U
Atherosclerosis; 2019 Feb; 281():17-24. PubMed ID: 30594773
[TBL] [Abstract][Full Text] [Related]
30. Independent regulation of plasma apolipoprotein C-II and C-III concentrations in very low density and high density lipoproteins: implications for the regulation of the catabolism of these lipoproteins.
Le NA; Gibson JC; Ginsberg HN
J Lipid Res; 1988 May; 29(5):669-77. PubMed ID: 3411241
[TBL] [Abstract][Full Text] [Related]
31. Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetes.
Taskinen MR; Barter PJ; Ehnholm C; Sullivan DR; Mann K; Simes J; Best JD; Hamwood S; Keech AC;
Diabetologia; 2010 Sep; 53(9):1846-55. PubMed ID: 20526762
[TBL] [Abstract][Full Text] [Related]
32. Increased production of apolipoprotein B and its lipoproteins by oleic acid in Caco-2 cells.
Dashti N; Smith EA; Alaupovic P
J Lipid Res; 1990 Jan; 31(1):113-23. PubMed ID: 2313196
[TBL] [Abstract][Full Text] [Related]
33. Plasma apolipoprotein C-III levels, triglycerides, and coronary artery calcification in type 2 diabetics.
Qamar A; Khetarpal SA; Khera AV; Qasim A; Rader DJ; Reilly MP
Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1880-8. PubMed ID: 26069232
[TBL] [Abstract][Full Text] [Related]
34. Apolipoprotein C-III and its defined lipoprotein subspecies in relation to incident diabetes: the Multi-Ethnic Study of Atherosclerosis.
Aroner SA; Furtado JD; Sacks FM; Tsai MY; Mukamal KJ; McClelland RL; Jensen MK
Diabetologia; 2019 Jun; 62(6):981-992. PubMed ID: 30949716
[TBL] [Abstract][Full Text] [Related]
35. Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity.
Ooi EM; Watts GF; Sprecher DL; Chan DC; Barrett PH
J Clin Endocrinol Metab; 2011 Oct; 96(10):E1568-76. PubMed ID: 21816786
[TBL] [Abstract][Full Text] [Related]
36. Obesity favors apolipoprotein E- and C-III-containing high density lipoprotein subfractions associated with risk of heart disease.
Talayero B; Wang L; Furtado J; Carey VJ; Bray GA; Sacks FM
J Lipid Res; 2014 Oct; 55(10):2167-77. PubMed ID: 24966274
[TBL] [Abstract][Full Text] [Related]
37. [Relation of plasma glucose levels to serum lipids and apolipoproteins levels in middle and old age males].
Duan Y; Wu Z; Liu B
Hua Xi Yi Ke Da Xue Xue Bao; 2001 Sep; 32(3):382-4. PubMed ID: 12536570
[TBL] [Abstract][Full Text] [Related]
38. Plasma level of miR-93 is associated with higher risk to develop type 2 diabetic retinopathy.
Zou HL; Wang Y; Gang Q; Zhang Y; Sun Y
Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1159-1166. PubMed ID: 28382439
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of neutrophil gelatinase-associated lipocalin and sdLDL-C for coronary artery disease in patients with type 2 diabetes mellitus aged ≥ 65 years.
Chen Y; Fu Y; Wang S; Chen P; Pei Y; Zhang J; Zhang R; Niu G; Gu F; Li X
Cardiovasc Diabetol; 2022 Nov; 21(1):252. PubMed ID: 36397150
[TBL] [Abstract][Full Text] [Related]
40. Expression of human apolipoprotein A-I/C-III/A-IV gene cluster in mice induces hyperlipidemia but reduces atherogenesis.
Vergnes L; Baroukh N; Ostos MA; Castro G; Duverger N; Nanjee MN; Najib J; Fruchart JC; Miller NE; Zakin MM; Ochoa A
Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2267-74. PubMed ID: 11031214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
